Cite
HARVARD Citation
Manini, M. et al. (2018). Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Digestive and liver disease. 50 (9), pp. 944-953. [Online].